key: cord-0808149-e995ev2w
authors: Vermund, Sten H; Pitzer, Virginia E
title: Asymptomatic transmission and the infection fatality risk for COVID-19: Implications for school reopening
date: 2020-06-25
journal: Clin Infect Dis
DOI: 10.1093/cid/ciaa855
sha: f30636e8d907af8658dac3949639b6ce0761ad34
doc_id: 808149
cord_uid: e995ev2w

Asymptomatic infection occurs for numerous respiratory viral diseases, including influenza and COVID-19. We seek to clarify confusion in three areas: age-specific risks of transmission and/or disease; various definitions for the COVID-19 “mortality rate”, each useful for specific purposes; and implications for student return strategies from pre-school through university settings.

A c c e p t e d M a n u s c r i p t Symptomatic persons may harbor high viral loads and be more likely to sneeze or cough, thereby projecting droplets and smaller aerosols more efficiently. Nonetheless, many symptomatic persons may self-segregate and voluntarily reduce the number of people they come into contact with, 15 such that transmission risk may be highest at or just before symptom onset, [11] [12] [13] [14] or from individuals who are asymptomatic or only mildly symptomatic.

After all, when someone has respiratory symptoms, that person may still care for family members, participate in group social activities, and/or go to work, especially when sick-leave policies are constrained. [15] [16] [17] To minimize transmission from asymptomatic individuals depends upon wearing masks, practicing physical distancing (2 meters or more), safe handand face-hygiene, cleansing surfaces, avoiding crowds and crowding, and aggressive viral testing and quarantine. [18] [19] [20] [21] [22] [23] [24] Measuring mortality: It's confusing, but does not have to be Frequency of asymptomatic infection in COVID-19 is related to obfuscation by popular and even scientific media vis-à-vis "mortality rates". Wide variations of so-called "mortality rates" from COVID-19 are reported, but confusion exists regarding definitions and selection biases affecting both the numerator and denominator. 25 A true mortality rate is the number of deaths per total population per time interval, as with estimating true COVID-19-related deaths from excess mortality rates. 26 But many other so-called "mortality rate" estimates are more accurately termed a case fatality risk (CFR; or a case fatality rate if assessed over a defined time period) since they derive from denominators of tested persons, omitting persons with mild disease or without symptoms who were never tested from the denominator. 27 (Suboptimal access to antigen/PCR/viral testing has been the global norm.) CFRs may differ based on background population characteristics; Chinese and Italian CFRs were 2.3 and 7.2%, respectively, likely reflecting the greater proportion of elderly afflicted in Italy. 28 A CFR is useful for measuring health systems metrics (e.g., delayed time to care, influence of comorbidities, or quality of health care), but they overestimate true mortality risks. 29 Surveys can guide more accurate assessments of the infection fatality risk (IFR; also can be a rate, A c c e p t e d M a n u s c r i p t over a defined time period), or risk of death among those symptomatically or asymptomatically infected, which is arguably more meaningful to considerations of societal reopening.

A Santa Clara County, California quasi-representative Facebook-based survey of residents in early April 2020 suggested a range of 48,000-81,000 infected persons, or a population prevalence of 2.5-4.2%. 30 There were 140 deaths from COVID-19 as of May 29, 2020. 31 While calculations are imperfect given time lags, 32 the estimated IFR would be 0.17-0.29%.

The IFR is always lower than the CFR for the respiratory viruses. The CFR includes persons tested in the denominator, with symptomatic persons far better represented. The IFR is based on population-level denominator estimates, typically from surveys, such that the denominator better estimates the true infections, many of which would have been asymptomatic (or only mildly symptomatic) and would not have presented for testing.

Epidemiologists and public health modelers use IFR to assess true lethality of a given infectious agent. Health care providers use CFR to assess quality of care and timeliness of clinical presentation and quality of care. When more representative, population-based serosurveys are available 33 and the true IFR can be estimated, 34 we project that a U.S.-wide IFR of 0.1-1% will be confirmed. To put this into perspective, if we were to assume that ~60% of the population will eventually be infected as we gradually approach the herd immunity threshold (=1-1/R 0 ) over several years without a vaccine or effective treatment and only imperfect preventive measures, and if we assume an IFR of 0.5% and a U.S. population of 331 million, then we could see nearly 1 million deaths (0.6*0.005*331,000,000) in the US.

The final size of the epidemic is expected to be even larger if the epidemic goes unchecked.

A comparison with influenza is useful. The CFR of COVID-19 is higher than the CFR of influenza, 34, 35 and the COVID-19 IFR is about 100 times higher than 1-10/100,000 estimates of the IFR for the 2009 pandemic influenza H1N1pdm09 virus. 35 Better IFR estimates are needed with more valid, accessible, and affordable point of care diagnostics. We believe A c c e p t e d M a n u s c r i p t that therapies and vaccines are forthcoming, but these calculations remind us of the urgency of maintaining physical distancing, face covering, hand/face/surface hygiene, testing/quarantine, and crowd control until new tools for therapy and prevention are available and deployed.

The issues of asymptomatic disease and IFR are highly relevant to school reopening decisions. Asymptomatic disease and mild disease that can resemble the common cold or influenza are common in children with COVID-19, and children have low case fatality risks. 36, 37 Principal concerns for SARS-CoV-2 infection in children include the infected child serving as a nidus of transmission to others, and, rarely, severe disease in the infected child as with multisystem inflammatory syndrome in children (MIS-C). [37] [38] [39] On average, children in the pre-school and kindergarten to 12 th grade (K-12) continuum come into contact with more people than the rest of the population; they typically do not adhere to hand-hygiene and physical distancing, though mask use may be better encouraged and enforced if teachers are motivated. 40 Thus, children are exceedingly good at spreading respiratory and fecal-oral infections. University students are generally young and healthy, and thereby also less likely to experience the severe COVID-19 disease, but they nevertheless pose a transmission risk to others in the community. University students who are in-residence in dormitories share risks like meningococcus, pertussis, and mumps, as occur in other crowded, high-risk environments, e.g. barracks, factories, prisons, long-term care facilities, and cruise or naval ships.

Deaths in youth are far less frequent than is their representation in the general population.

For example, 45% of the U.S. population in 2019 were under 35 years of age, yet these represented less than 1% of COVID-19 deaths (Table) . The principal concern with transmission in schools is that outbreaks can affect the older and/or more vulnerable individuals (e.g., teachers, school workers, volunteers, grandparents, or A c c e p t e d M a n u s c r i p t immunocompromised children or adults) who are in proximity to school children. Also relevant is what we see each influenza season, namely school and family disruption of large numbers of children ill at any given time. Hence, it is incumbent on us all to reopen schools as safely as we can, to step up "gateway" testing opportunities (testing all children, staff, and faculty in the weeks just prior to school opening, with periodic retesting if feasible) if background incidence rates in a given community suggest the benefits of such an approach, and practice aggressive distancing, hygiene, and mask use in the school setting. Universal flu vaccine is a must, to minimize influenza burdens on schools in the December-March time frame (in the northern temperate zones).

Costs will be incurred for personal protective equipment such as masks (including pediatric sizes), shields (advisable for close-in work, as with a science or art class), and gloves for cleaning. Logistics can be altered, as with one-way flow in corridors and stairwells. Heating, ventilation, and air conditioning (HVAC) systems can be reconfigured and adjusted to increase outdoor air exchange and/or filtering of air. Gymnasiums or lunchrooms or libraries can be used as classrooms to improve physical distancing. Outdoor activities (and even outdoor classrooms) can be encouraged. Issues around music, arts, drama, and sports are complex. A myriad of risk reduction methods can be used, acknowledging that risk of serious illness or death is most compelling ofr the contacts of infected students (both symptomatic and asymptomatic) far more than the students themselves. Immunologically vulnerable students may be best taught through distance learning settings. Children and parents/guardians, teachers/staff all can be educated as to why and how to stay safe.

In summary, asymptomatic transmission likely represents as substantial proportion of total new infections, such that IFRs are lower than some respiratory pathogens, though higher than for pandemic influenza. 41 Education and adherence may be most challenging in the very young student, as well as in the "invincible" adolescent, so how to enlist children themselves as allies in control of COVID-19 is a vital challenge. A more nuanced view of risk helps us maximize safety in reopening schools at every level of instruction, from pre-school A c c e p t e d M a n u s c r i p t to university. While we should not be paralyzed with fear for our children (polio or measles are far worse), the COVID-19 IRF is still far higher than for influenza. Neither exaggerated fears for our children (Table) nor naïveté as to the menace of resurgent disease 42 M a n u s c r i p t Funding V.E.P. reports grants R01AI112970 and R01AI137093 from NIH/NIAID, during the conduct of the study; Potential Conflicts of Interest V.E.P. reports travel expenses to attend Scientific Input Engagement from Merck and Pfizer, outside the submitted work; and is a member of the WHO Immunization and Vaccine-related Implementation Research Advisory Committee (IVIR-AC). No conflicts reported by S.T.V. M a n u s c r i p t 

Severe Acute Respiratory Syndrome: Historical, epidemiologic, and clinical features

Emerging respiratory infections: The infectious disease pathology of SARS, MERS, pandemic influenza, and Legionella

Bats and coronaviruses

Martin-Loeches I. influenza infections and emergent viral infections in intensive care unit

Respiratory syncytial virus infection in adults

Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review

Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)

Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship

WHO walks back comments on asymptomatic transmission of coronavirus

Temporal dynamics in viral shedding and transmissibility of COVID-19

Virological assessment of hospitalized patients with COVID-2019

Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study

Asymptomatic and presymptomatic transmission of SARS-CoV-2: A systematic review. medRxiv

Evaluating costs and health consequences of sick leave strategies against pandemic and seasonal influenza in Norway using a dynamic model

Dynamic modelling of costs and health consequences of school closure during an influenza pandemic

Child influenza vaccination and adult work loss: Reduced sick leave use only in adults with paid sick leave

Modeling control strategies of respiratory pathogens

Applying principles of behaviour change to reduce SARS-CoV-2 transmission

Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis

Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China

the case for universal cloth mask adoption and policies to increase supply of medical masks for health workers

Identifying airborne transmission as the dominant route for the spread of COVID-19

To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic

Modeling the impact of social distancing, testing, contact tracing and household quarantine on second-wave scenarios of the COVID-19 epidemic

Estimating the early death toll of COVID-19 in the United States

potential biases in estimating absolute and relative case-fatality risks during outbreaks

Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy

Case fatality: rate, ratio, or risk?

COVID-19 Antibody Seroprevalence

Santa Clara County Public Health Coronavirus (COVID-19) Data Dashboard

Estimates of the severity of coronavirus disease 2019: a model-based analysis

State-level tracking of COVID-19 in the United States

The infection fatality rate of COVID-19 inferred from seroprevalence data

Case fatality risk of influenza A (H1N1pdm09): a systematic review

New York City Swine Flu Investigation Team, et al. The severity of pandemic H1N1 influenza in the United States

Epidemiology of COVID-19 among children in China

Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults

COVID-19: The impact on pediatric emergency care

Social contacts and mixing patterns relevant to the spread of infectious diseases

Case fatality rates based on population estimates of influenza-like illness due to novel H1N1 influenza

Trump contradicts health officials on who can get a coronavirus test

A c c e p t e d M a n u s c r i p t